Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s disease

Mourad Chioua, Marta Pérez, Oscar M. Bautista-Aguilera, Matilde Yañez, Manuela G. López, Alejandro Romero, Ramón Cacabelos, Raimon Puig de la Bellacasa, Simone Brogi, Stefania Butini*, José I. Borrell, Jose Marco-Contelles

*Corresponding author for this work

Research output: Indexed journal article Reviewpeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s disease'. Together they form a unique fingerprint.

Chemistry

Pharmacology, Toxicology and Pharmaceutical Science